Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? - Wikidata - wikimedia - TriplyDB

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

http://www.wikidata.org/entity/Q34299285

about

A human gene coding for a membrane-associated nucleic acid-binding protein Design and application of multifunctional DNA nanocarriers for therapeutic delivery Physical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages.Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity.Enhancement of anti-herpetic activity of antisense phosphorothioate oligonucleotides 5' end modified with geraniol.Receptor-mediated endocytosis of phosphodiester oligonucleotides in the HepG2 cell line: evidence for non-conventional intracellular trafficking.Identification, purification and partial characterisation of an oligonucleotide receptor in membranes of HepG2 cells.Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process.Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide Silica nanoparticles as a delivery system for nucleic acid-based reagents.Molecular and cellular barriers limiting the effectiveness of antisense oligonucleotides.Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.Vehicles for oligonucleotide delivery to tumours.Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.Detection of covalent triplex within human cells Mechanisms for the control of gene activity during development.Inhibition of gene transcription by purine rich triplex forming oligodeoxyribonucleotides In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides Differential distribution of oligodeoxynucleotides in developing organs with epithelial-mesenchymal interactions Quantification of rare circulating tumor cells in non-small cell lung cancer by ligand-targeted PCR.In vivo imaging with oligonucleotides for diagnosis and drug development.The future of antisense therapy: combination with anticancer treatments.Inhibitory effect of ribbon-type NF-kappaB decoy oligodeoxynucleotides on osteoclast induction and activity in vitro and in vivo Traditional biochemical assays for studying toll-like receptor 9.Inhibition of proopiomelanocortin expression by an oligodeoxynucleotide complementary to beta-endorphin mRNA.Interactions of antisense DNA oligonucleotide analogs with phospholipid membranes (liposomes).Cyclodextrins and oligonucleotide delivery to solid tumours.Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice.Identification and characterization of a cell membrane nucleic acid channel.A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain Modification of antisense phosphodiester oligodeoxynucleotides by a 5' cholesteryl moiety increases cellular association and improves efficacy Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.Ex vivo programming of antigen-presenting B lymphocytes: considerations on DNA uptake and cell activation.Cellular uptake and biological effects of antisense oligodeoxynucleotide analogs targeted to herpes simplex virus.Properties of internalization factors contributing to the uptake of extracellular DNA into tumor-initiating stem cells of mouse Krebs-2 cell line.Bioconjugation of oligonucleotides for treating liver fibrosis.Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.Antisense agents in cancer research and therapeutics.

P2860

Q22254772-EF6117B4-559B-4F62-A55C-4EC2B702F041 Q27007011-214859FC-D799-478D-B20A-6C726CF94DC7 Q29041754-7372780E-BF62-4720-A1BD-5173D2DC9D3A Q29544231-39A0D759-F1BA-433F-AD9D-78154F945A3B Q31009736-072C98BC-BE6C-4D8F-ACD0-5D6DC8822672 Q32035441-04DE8E91-4E3A-4F87-9AC3-D7A694F7AA59 Q33601089-2226C3FB-314E-4D38-B23A-F9351BC60908 Q33614680-90E55F1A-0745-4DA4-B8EF-1B1A8BB39311 Q33754501-C33FFA23-EA7C-42F2-B482-8087E87A25FC Q33917462-C1916750-1B21-4F0D-B542-732F494FD0B8 Q33978043-B632288D-AE91-40BC-A9B0-EA52C345A68A Q34080775-F61897AB-CBF8-4639-A5B7-C0D7EA0DA53F Q34351307-5D832DE3-0035-4675-9C59-79D8868E1E7A Q34366036-F0C8D264-9D4A-4F51-9425-02782DBDF287 Q34518719-0D43FDA9-1478-48D1-BE71-4B4E7F7DC5BF Q34582428-1E1674C3-DC63-466B-B955-620DBAD237F1 Q34615624-D87083FF-88F0-4D2A-B515-4C5568AE2FC5 Q34638690-394534F9-BE8A-4254-8B35-1277C20BDE24 Q34987749-E1FF8DFD-6D4E-49C4-B189-0A9258D6E452 Q35012323-05013B59-C203-47B5-94FE-FC95A945C324 Q35042688-719B6D44-CF78-458D-AB0D-FE52DF1A614D Q35063733-7C28196E-F3DA-4CD9-9C8D-BF936E7AE684 Q35127223-322FA611-3C2E-4928-8BE7-3204FF32A818 Q35551139-D89CC223-602F-4889-AE4D-54C5AB81BF86 Q35605522-C01CCC2E-0A2C-48B4-B72F-53164AEBD838 Q35671392-27AC628F-BA9D-42CE-B9A0-637A59BE2029 Q35680622-27C63DC7-B1A5-4AA1-9980-6E27C83A034F Q35787945-5AA3B031-A636-4745-B445-47901CE52EA6 Q35809234-C06D9B85-01F8-4C1E-B082-8F0358EA4465 Q35856548-844EF4EB-8EAF-4E40-930B-0F3DFA294044 Q35896079-1F78AE5D-F680-49D6-94A8-728BB6258714 Q36029867-49D777E4-BAE7-4179-B173-1221C15BDDEE Q36087670-CD299749-2B8B-4403-B41C-DAD3CDC47E14 Q36316652-1AA8F9DF-7C61-4609-AD11-1A22178C8DFA Q36526337-EB3D4FA0-7CF7-4BC3-BBFB-7249F90F1014 Q36819700-14CE48A0-FA8E-455D-B9DF-D492BE269B5B Q36938161-B0563061-A0ED-4202-A2EB-483EB5CC7D95 Q37043515-27131F04-85CD-4877-9848-ABC7A34E85C0 Q37210126-E68E8C02-A43C-4AED-BE74-070793211489 Q37220809-CBF5FB5A-C1BF-4990-A0D9-2AF9654B41E1

P2860

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

http://www.wikidata.org/entity/Q34299285

description

1989 nî lūn-bûn

@nan

1989 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1989 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1989年の論文

@ja

1989年論文

@yue

1989年論文

@zh-hant

1989年論文

@zh-hk

1989年論文

@zh-mo

1989年論文

@zh-tw

1989年论文

@wuu

name

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@ast

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@en

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@nl

type

label

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@ast

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@en

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@nl

prefLabel

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@ast

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@en

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@nl

P1433

Q34299285-95C85A0F-D503-48E4-B7C0-CC6F3649079D

P1476

Q34299285-7E977205-2BAA-41B6-BDFC-010D5A0E0E13

P2093

Q34299285-13145441-0B13-440D-9D86-32570060A9E4

Q34299285-3600970C-6056-4DAE-8C4C-1155B9518497

Q34299285-6520E609-C32A-49B1-86E3-3E3F325C7D6D

Q34299285-89FEF824-527C-4765-AF6E-0867AE7E7A87

Q34299285-EB42AFC3-8531-4842-AE36-90F0C4AAFF6D

Q34299285-FC5C9F03-7479-4057-99C9-93E16A320413

Q34299285-FDD92B6B-0F05-4B06-9DBA-1CFE51C999F1

P2860

Q34299285-0ABB76E4-D04A-450A-A948-7499EC17311D

Q34299285-0CDF3FDA-C239-4D72-8E8D-B8ADBBBC3FD2

Q34299285-20B186E5-48BE-47FB-929F-2B4FFCC99DBE

Q34299285-311F5C20-43C0-4B24-964E-C67D1459694B

Q34299285-7EB7B6E6-0AF2-4845-A964-E5698977A8F7

Q34299285-896442EC-4A36-4555-A0FB-2492DD8C06EA

Q34299285-9E17E4A7-FA08-40CE-8A19-76B3EBB5A32C

Q34299285-A3324526-E7A5-415B-87DE-306397F55CE6

Q34299285-B17CA008-8AC2-4258-BE4A-65EAF7681E16

Q34299285-C674BB41-2BD7-4DB2-A71B-717C7A8C9193

P304

Q34299285-7DCF0E11-3070-4420-A5F3-9457A467FDB8

P31

Q34299285-544662BC-8D65-48A0-B09F-78787961935A

P356

Q34299285-66F88173-666E-4AA3-A0D3-8AE982220546

P407

Q34299285-B061ECC3-F86F-453A-BF43-0DAE4865C01E

P433

Q34299285-31A4C41B-9282-45B8-AFC1-B48255E8B25E

P478

Q34299285-6C77A5A2-7A00-4B28-8057-3B5AE14A7570

P577

Q34299285-6378CA9E-1DEE-46A2-8263-450475FB553B

P5875

Q34299285-CF0A6A5C-D9BA-47E4-B1CE-5115F03053E2

P698

Q34299285-AFE73A06-48A3-4D4F-A11D-1274B4D339A6

P932

Q34299285-674EB96B-7F93-42B7-B735-CEC4CD9DF661

P356

PNAS.86.17.6454

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

@en

P2093

Deeva EA

http://www.w3.org/2001/XMLSchema#string

Ivanova EM

http://www.w3.org/2001/XMLSchema#string

Ryte AS

http://www.w3.org/2001/XMLSchema#string

Vlassov VV

http://www.w3.org/2001/XMLSchema#string

Yakubov LA

http://www.w3.org/2001/XMLSchema#string

Yurchenko LV

http://www.w3.org/2001/XMLSchema#string

Zarytova VF

http://www.w3.org/2001/XMLSchema#string

P2860

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Endocytosis: relation to capping and cell locomotion

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.

Characterization of oligonucleotide transport into living cells.

A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: Matagen (masking tape for gene expression).

Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

Complementary-addressed (sequence-specific) modification of nucleic acids.

Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Chemical aspects.

The pinocytosis of 125I-labelled poly(vinylpyrrolidone), [14C]sucrose and colloidal [198Au]gold by rat yolk sac cultured in vitro.

P304

6454-6458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.86.17.6454

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

86

http://www.w3.org/2001/XMLSchema#string

P577

1989-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20605690

http://www.w3.org/2001/XMLSchema#string

P698

2549537

http://www.w3.org/2001/XMLSchema#string

P932

297862

http://www.w3.org/2001/XMLSchema#string